United States Inflammatory Bowel Disease Drugs Sales Market Report 2021

◆商品コード:QYR60932615
◆発行会社(リサーチ会社):QYResearch
◆発行日:2016年7月25日
◆ページ数:122
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single UserUSD3,800 ⇒換算¥418,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD4,940 ⇒換算¥543,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

This report studies sales (consumption) of Inflammatory Bowel Disease Drugs in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering_x000D_ Merck & Company_x000D_
Janssen Pharmaceuticals_x000D_
Abbvie_x000D_
Biogen Idec_x000D_
UCB_x000D_
Shire_x000D_
Pfizer_x000D_
Novartis_x000D_
Novo Nordisk_x000D_
Boehringer Ingelheim_x000D_
Salix Pharmaceuticals_x000D_
Genentech_x000D_
Amgen_x000D_
Mitsubishi Tanabe_x000D_
Akebia Therapeutics_x000D_
Celltrion_x000D_
ChemoCentryx_x000D_
Ferring Pharmaceuticals_x000D_
_x000D_
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into_x000D_
Type I_x000D_
Type II_x000D_
Type III_x000D_
Split by applications, this report focuses on sales, market share and growth rate of Inflammatory Bowel Disease Drugs in each application, can be divided into_x000D_
Application 1_x000D_
Application 2_x000D_
Application 3_x000D_
_x000D_

【レポートの目次】

Table of Contents_x000D_
_x000D_
United States Inflammatory Bowel Disease Drugs Sales Market Report 2021_x000D_
1 Inflammatory Bowel Disease Drugs Overview_x000D_
1.1 Product Overview and Scope of Inflammatory Bowel Disease Drugs_x000D_
1.2 Classification of Inflammatory Bowel Disease Drugs_x000D_
1.2.1 Type I_x000D_
1.2.2 Type II_x000D_
1.2.3 Type III_x000D_
1.3 Applications of Inflammatory Bowel Disease Drugs_x000D_
1.3.1 Application 1_x000D_
1.3.2 Application 2_x000D_
1.3.3 Application 3_x000D_
1.4 USA Market Size (Value and Volume) of Inflammatory Bowel Disease Drugs (2011-2021)_x000D_
1.4.1 USA Inflammatory Bowel Disease Drugs Sales, Revenue and Price (2011-2021)_x000D_
1.4.2 USA Inflammatory Bowel Disease Drugs Sales and Growth Rate (2011-2021)_x000D_
1.4.3 USA Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2011-2021)_x000D_
_x000D_
2 USA Inflammatory Bowel Disease Drugs Competition by Manufacturers_x000D_
2.1 USA Inflammatory Bowel Disease Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)_x000D_
2.2 USA Inflammatory Bowel Disease Drugs Revenue and Share by Manufactures (2015 and 2016)_x000D_
_x000D_
3 USA Inflammatory Bowel Disease Drugs (Volume and Value) by Type_x000D_
3.1 USA Inflammatory Bowel Disease Drugs Sales and Market Share by Type (2011-2021)_x000D_
3.2 USA Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2011-2021)_x000D_
_x000D_
4 USA Inflammatory Bowel Disease Drugs (Volume) by Application_x000D_
_x000D_
5 USA Inflammatory Bowel Disease Drugs Manufacturers Analysis_x000D_
5.1 Merck & Company_x000D_
5.1.1 Company Basic Information, Manufacturing Base and Competitors_x000D_
5.1.2 Inflammatory Bowel Disease Drugs Product Type and Technology_x000D_
5.1.2.1 Type I_x000D_
5.1.2.2 Type II_x000D_
5.1.3 Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Merck & Company (2015 and 2016)_x000D_
5.2 Janssen Pharmaceuticals_x000D_
5.2.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.2.2 Pharmaceuticals Product Type and Technology_x000D_
5.2.2.1 Type I_x000D_
5.2.2.2 Type II_x000D_
5.2.3 Pharmaceuticals Sales, Revenue, Price of Janssen Pharmaceuticals (2015 and 2016)_x000D_
5.3 Abbvie_x000D_
5.3.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.3.2 Abbvie Product Type and Technology_x000D_
5.3.2.1 Type I_x000D_
5.3.2.2 Type II_x000D_
5.3.3 Abbvie Sales, Revenue, Price of Abbvie (2015 and 2016)_x000D_
5.4 Biogen Idec_x000D_
5.4.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.4.2 Novo Nordisk Product Type and Technology_x000D_
5.4.2.1 Type I_x000D_
5.4.2.2 Type II_x000D_
5.4.3 Biogen Idec Sales, Revenue, Price of Biogen Idec (2015 and 2016)_x000D_
5.5 UCB_x000D_
5.5.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.5.2 UCB Product Type and Technology_x000D_
5.5.2.1 Type I_x000D_
5.5.2.2 Type II_x000D_
5.5.3 UCB Sales, Revenue, Price of UCB (2015 and 2016)_x000D_
5.6 Shire_x000D_
5.6.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.6.2 Shire Product Type and Technology_x000D_
5.6.2.1 Type I_x000D_
5.6.2.2 Type II_x000D_
5.6.3 Shire Sales, Revenue, Price of Shire (2015 and 2016)_x000D_
5.7 Pfizer_x000D_
5.7.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.7.2 Pfizer Product Type and Technology_x000D_
5.7.2.1 Type I_x000D_
5.7.2.2 Type II_x000D_
5.7.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)_x000D_
5.8 Novartis_x000D_
5.8.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.8.2 Novartis Product Type and Technology_x000D_
5.8.2.1 Type I_x000D_
5.8.2.2 Type II_x000D_
5.8.3 Novartis Sales, Revenue, Price of Novartis (2015 and 2016)_x000D_
5.9 Novo Nordisk_x000D_
5.9.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.9.2 Novo Nordisk Product Type and Technology_x000D_
5.9.2.1 Type I_x000D_
5.9.2.2 Type II_x000D_
5.9.3 Novo Nordisk Sales, Revenue, Price of Novo Nordisk (2015 and 2016)_x000D_
5.10 Boehringer Ingelheim_x000D_
5.10.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.10.2 Boehringer Ingelheim Product Type and Technology_x000D_
5.10.2.1 Type I_x000D_
5.10.2.2 Type II_x000D_
5.10.3 Boehringer Ingelheim Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)_x000D_
5.11 Salix Pharmaceuticals_x000D_
5.12 Genentech_x000D_
5.13 Amgen_x000D_
5.14 Mitsubishi Tanabe_x000D_
5.15 Akebia Therapeutics_x000D_
5.16 Celltrion_x000D_
5.17 ChemoCentryx_x000D_
5.18 Ferring Pharmaceuticals_x000D_
_x000D_
6 Inflammatory Bowel Disease Drugs Technology and Development Trend_x000D_
6.1 Inflammatory Bowel Disease Drugs Technology Analysis_x000D_
6.2 Inflammatory Bowel Disease Drugs Technology Development Trend_x000D_
_x000D_
7 Research Findings and Conclusion_x000D_
_x000D_
_x000D_

List of Tables and Figures _x000D_
_x000D_
Figure Picture of Inflammatory Bowel Disease Drugs_x000D_
Table Classification of Inflammatory Bowel Disease Drugs_x000D_
Figure USA Sales Market Share of Inflammatory Bowel Disease Drugs by Type in 2015_x000D_
Table Applications of Inflammatory Bowel Disease Drugs_x000D_
Figure USA Sales Market Share of Inflammatory Bowel Disease Drugs by Application in 2015_x000D_
Table USA Inflammatory Bowel Disease Drugs Sales, Revenue and Price (2011-2021)_x000D_
Figure USA Inflammatory Bowel Disease Drugs Sales and Growth Rate (2011-2021)_x000D_
Figure USA Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2011-2021)_x000D_
Table USA Inflammatory Bowel Disease Drugs Sales of Key Manufacturers (2015 and 2016)_x000D_
Table USA Inflammatory Bowel Disease Drugs Sales Share by Manufacturers (2015 and 2016)_x000D_
Figure 2015 Inflammatory Bowel Disease Drugs Sales Share by Manufacturers_x000D_
Figure 2016 Inflammatory Bowel Disease Drugs Sales Share by Manufacturers_x000D_
Table USA Inflammatory Bowel Disease Drugs Revenue by Manufacturers (2015 and 2016)_x000D_
Table USA Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers (2015 and 2016)_x000D_
Table 2015 USA Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers_x000D_
Table 2016 USA Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers_x000D_
Table USA Inflammatory Bowel Disease Drugs Sales and Market Share by Type (2011-2021)_x000D_
Table USA Inflammatory Bowel Disease Drugs Sales Share by Type (2011-2021)_x000D_
Figure Sales Market Share of Inflammatory Bowel Disease Drugs by Type (2011-2021)_x000D_
Figure USA Inflammatory Bowel Disease Drugs Sales Growth Rate by Type (2011-2021)_x000D_
Table USA Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2011-2021)_x000D_
Table USA Inflammatory Bowel Disease Drugs Revenue Share by Type (2011-2021)_x000D_
Figure Revenue Market Share of Inflammatory Bowel Disease Drugs by Type (2011-2021)_x000D_
Figure USA Inflammatory Bowel Disease Drugs Revenue Growth Rate by Type (2011-2021)_x000D_
Table USA Inflammatory Bowel Disease Drugs Sales and Market Share by Application (2011-2021)_x000D_
Table USA Inflammatory Bowel Disease Drugs Sales Share by Application (2011-2021)_x000D_
Figure Sales Market Share of Inflammatory Bowel Disease Drugs by Application (2011-2021)_x000D_
Figure USA Inflammatory Bowel Disease Drugs Sales Growth Rate by Application (2011-2021)_x000D_
Table Merck & Company Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Merck & Company (2015 and 2016)_x000D_
Table Janssen Pharmaceuticals Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Janssen Pharmaceuticals (2015 and 2016)_x000D_
Table Abbvie Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Abbvie (2015 and 2016)_x000D_
Table Biogen Idec Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Biogen Idec (2015 and 2016)_x000D_
Table UCB Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of UCB (2015 and 2016)_x000D_
Table Shire Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Shire (2015 and 2016)_x000D_
Table Pfizer Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Pfizer (2015 and 2016)_x000D_
Table Novartis Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Novartis (2015 and 2016)_x000D_
Table Novo Nordisk Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Novo Nordisk (2015 and 2016)_x000D_
Table Boehringer Ingelheim Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)_x000D_
Table Salix Pharmaceuticals Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Salix Pharmaceuticals (2015 and 2016)_x000D_
Table Genentech Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Genentech (2015 and 2016)_x000D_
Table Amgen Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Amgen (2015 and 2016)_x000D_
Table Mitsubishi Tanabe Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Mitsubishi Tanabe (2015 and 2016)_x000D_
Table Akebia Therapeutics Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Akebia Therapeutics (2015 and 2016)_x000D_
Table Celltrion Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Celltrion (2015 and 2016)_x000D_
Table ChemoCentryx Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of ChemoCentryx (2015 and 2016)_x000D_
Table Ferring Pharmaceuticals Basic Information List_x000D_
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Ferring Pharmaceuticals (2015 and 2016)_x000D_
_x000D_


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ United States Inflammatory Bowel Disease Drugs Sales Market Report 2021]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆